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Preface 
Immunology, though deeply experimental in everyday practice, is also a theoretical discipline. 
Recent advances in the understanding of innate immunity, how it is triggered, and how it 
shares features previously uniquely ascribed to the adaptive immune system, can contribute to 
the refinement of immunology’s theoretical framework. In particular, natural killer (NK) cells 
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and macrophages are activated by transient modifications, but adapt to long-lasting 
modifications that occur in the surrounding tissue environment. This process allows the 
maintenance of self-tolerance while permitting efficient immune responses. Extending this 
idea to other components of the immune system, we propose here some general principles that 
lay the ground for a unifying account of immunity, the discontinuity theory. According to this 
theoretical framework, effector immune responses (i.e., activated responses that lead to the 
potential elimination of the target antigen) are triggered by an antigenic discontinuity, that is, 
by the sudden modification of molecular motifs with which immune cells interact.  
 
Introduction 
For more than a century, immunologists have elaborated theories to provide 
descriptions, explanations and predictions about how an immune response is triggered. So 
much interest in theories in a field of molecular biology is somewhat uncommon1, but it has 
undoubtedly been very fruitful. Yet, confronted with the difficulties encountered by some of 
these theories2, several immunologists might be tempted to abandon the ambition to build 
what they see as grand theories, preferring instead to focus on the elucidation of the molecular 
mechanisms of immune responses. Nevertheless, theories are essential to interpret 
observations and develop new research hypotheses (BOX 1). We are therefore convinced that 
the elaboration of theories should remain associated with advances in immunology. In this 
Essay, we propose a new theoretical framework that aims to explain how immune cells 
integrate spatial, temporal, quantitative and qualitative signals to mount a response. We start 
with the case of natural killer (NK) cells, and then extend our framework to other immune 
cells. 
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The dynamics of natural killer cell reactivity 
NK cells are innate lymphoid cells that produce cytokines and can be cytolytic3,4. They 
distinguish their cellular targets from healthy cells via a panel of activating and inhibitory cell 
surface receptors, as well as adhesion molecules. Most NK cell activating receptors recognize 
cell surface ligands that are induced on modified cells, for example following tumor 
transformation, microbial infection, or physical and chemical assaults5. This recognition of 
dysregulated self allows NK cells to be selectively activated by host cells that have undergone 
molecular modifications, and are in some way stressed. Prototypical examples of NK cell 
surface receptors that function according to this mode of recognition include NKG2D and 
NKp30. In contrast, NK cell inhibitory receptors recognize cell surface molecules that are 
readily expressed at steady-state on most cells, such as killer cell immunoglobulin-like 
receptors (KIRs) and Ly49 molecules that recognize MHC class I molecules in humans and 
mice, respectively. This mode of recognition allows NK cells to be selectively activated by 
cells that have received stress signals leading to the downregulation of constitutively 
expressed molecules, such as the loss of MHC class I expression upon cytomegalovirus 
infection, and is thus referred to as ‘missing self’ recognition6. By integrating activating and 
inhibitory signals upon encountering a given interacting cell, NK cells thus spare normal cells 
and contribute to the elimination of cells expressing strongly modified motifs (FIG. 1A). 
Importantly, the responsiveness of NK cells decreases in the case of a chronic engagement of 
various activating receptors, such as NKG2D, human activating KIRs (e.g. KIR2DS1) or 
mouse activating Ly49 molecules (e.g. Ly49H) (FIG. 1B). Similarly, whereas NK cells 
grown in a MHC class I-sufficient environment can eliminate MHC class I-negative cells, NK 
cells grown in or transferred to a MHC class I-deficient environment are no longer able to do 
so (FIG. 1C)7,8,9,10. Thus, NK cells detect sudden modifications of their environment, but 
when modified motifs are long lasting, NK cells adapt to them by ceasing to be responsive. 
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These observations lay the ground for a new theoretical framework, the ‘discontinuity theory’, 
proposing that immune cells trigger an effector response when there is a discontinuity in the 
molecular motifs with which their receptors interact, while they tend to become tolerant to 
continuously expressed motifs.  
 
Extending the discontinuity theory to other immune cells 
Several families of innate immune cells also respond to a sudden modification of their 
ligands. Macrophages, in particular, respond not only to microorganisms but also to modified 
host cells11,12,13. The molecular targets in such cases include pre-expressed host molecules that 
show biochemical modifications such as oxidation in the sugar chains of glycoproteins and 
glycolipids, molecules that show neo-expression as a result of cellular stress such as 
thrombospondin 1, or intracellular molecules that relocalize to the cell membrane after injury 
such as phosphatidylserine, DNA, endoplasmic reticulum-resident proteins or F-actin14,15. 
Crucially, macrophages also adapt to long-lasting motifs in their environment. This adaptation 
is illustrated by the well-known phenomenon of endotoxin tolerance, a process by which by 
which cells exposed to low concentrations of endotoxin become hyporesponsive to further 
challenges with endotoxin, thereby avoiding the potentially harmful effects caused by the 
continual presence of pro-inflammatory stimuli16. Along the same line, phagocytosis of 
potential target cells is blocked when macrophages detect CD47 (a transmembrane protein 
that is ubiquitously expressed by host cells) via the inhibitory receptor signal-regulatory 
protein 1α (SIRP1α). As a consequence, when a macrophage encounters a CD47-deficient 
erythrocyte, it phagocytoses it, as the inhibitory macrophage receptor SIRP1α is no longer 
engaged by CD47. However, macrophages from CD47-deficient mice do not phagocytose 
CD47-deficient erythrocytes17. Hence, the discontinuity theory applies very well to 
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macrophages, which sense changes in their environment but adapt to these changes when they 
become persistent.  
Could the same concept be extended to other immune cells, such as T and B cells? The 
activation of these lymphocytes is admittedly much more complex, in particular because they 
undergo a thorough selection process in primary lymphoid organs where, in theory, 
potentially self-reactive lymphocytes are removed. Yet several data hint at a possible 
discontinuity-based mechanism of immune activation in T and B cells. In particular, it is well 
established that conventional T and B cells are anergized when an antigen is chronically or 
constantly present18,19. For instance, several chronic infections cause functional exhaustion or 
deletion of antigen-specific conventional αβ T cells20,21. Similarly, the chronic exposure of 
non-conventional mouse γδ T cells (Vγ5Vδ1) to Skint1, a prototypic member of a novel 
family related to butyrophilin-like molecules, led to their hyporesponsiveness22. All these 
observations may contribute to a renewal of the ‘tunable activation threshold’ model, 
according to which lymphocytes sense relative changes, rather than absolute strength, and 
respond only if a sufficiently rapid increase in their level of stimulation occurs23,24. 
Undoubtedly, more work will be needed to determine whether the discontinuity theory applies 
to T and B cells. For the moment, suffice it to say that this theory aims primarily at explaining 
innate immune responses, which is key to understanding immune responses in general25. 
Lastly, an area in which the framework presented here seems particularly relevant is 
that of tumour immunology. It is now well established that tumours give rise to effector 
immune responses26,27,28,29,30. Though tumour cells are, genetically speaking, self cells, they are 
transformed cells that possess several features that distinguish them from healthy host cells, 
particularly the expression of abnormal motifs at their cell surface28,31. Effector immune 
responses to tumours can be explained by the apparition of these strongly modified patterns. 
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Conversely, several experiments showed that a persistent tumour antigen diminishes the 
efficacy of the antitumour response32,33. 
 
The core of the discontinuity theory 
Antigenic discontinuity 
We believe that a very simple theoretical framework can unify under a single explanatory 
principle the diverse immunological data presented above. We call this framework the 
‘discontinuity theory’. In a nutshell, it states that effector immune responses are triggered by 
an antigenic discontinuity, that is, by the appearance of molecular motifs that are qualitatively 
or quantitatively different from those with which the immune system has regularly interacted 
so far. Note that an antigen is defined here as any entity with which immune receptors, innate 
or adaptive, interact. The criterion of immunogenicity that we adopt is antigenic discontinuity 
itself, and not the origin of the antigen: indeed, a discontinuity can appear at the level of self 
motifs (for example, a tumour), as well as non-self motifs (for example, a microbe)34. From 
this point of view, the framework presented here echoes the concepts of immune 
surveillance35,36,37, and altered self38,39, incorporating them in a more comprehensive 
perspective. More generally, the idea that antigenic discontinuity is immunogenic can be 
related to the common and well supported principle according to which biological entities 
react to variations in stimuli, as it has been demonstrated for the sight for instance40,41,42.  
  
A response based on the variation of the quantities of antigens with regard to time 
The central statement of the discontinuity theory is that an effector immune response occurs 
as a function of the variation of quantities of antigen (dQ) with regard to time (dt), that is the 
value dQ/dt (BOX2 details how the variation can be modeled with respect to time). Indeed, 
two key factors in the triggering of an immune response are the speed at which antigens 
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appear, and the duration of antigen exposure. In addition, two aspects must be taken into 
account. First, the spatial aspect: the localization of the immune interaction is pivotal, as 
immune responses are regulated by the local environment, which is often characterized by the 
prevalence of different cell types (for example, the gut or the skin are very different in terms 
of their cellular composition). Therefore, what is important is the local antigenic 
discontinuity, because a given antigen can be immunogenic or not according to its 
localization. Second, the structural aspect: the degree of molecular difference between usual 
antigens with which immune receptors interact and the antigen under consideration is 
important. 
Now, why should the immune response be understood as a function of the variation of 
quantities of antigen with regard to time? In many cases, antigens appearing very 
progressively do not represent a strong modification and hence are not eliminated43,44. Motifs 
changing at a very high rate can make protective immune responses impossible, as happens 
with many parasites and viruses including HIV45,46,47. Indeed, in these conditions, the time 
required for the generation of protective immune response is greater than the time needed for 
the pathogens to mutate. As a consequence, these immune responses are constantly 
inadequate to the pathogen. The duration of the antigen exposure is also crucial, as cells 
exposed to chronic stimulations become desensitized by various mechanisms. Desensitization 
is by no means specific to immunity. In all living objects, the detection of changes in the 
environment of a cell (for example, the recognition of a stimulus by a cell surface receptor) is 
associated with the initiation of regulatory pathways that are either intrinsic or extrinsic to the 
stimulated cell. Desensitization of signaling pathways is a common cell intrinsic regulatory 
mechanism, and is an emerging property resulting from feedback and/or feedforward loops48. 
The mechanisms used to achieve desensitization include cell surface receptor internalization 
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recognition) and the degradation of key downstream signaling elements. Other cell intrinsic 
regulatory circuits include the activation of enzymatic pathways that counteract the signaling 
cascade initiated by the initial stimulus. For example, receptors bearing immunoreceptor 
tyrosine-based inhibition motifs (ITIMs) recruit and activate phosphatases that antagonize the 
activating kinases triggered by the receptors bearing immunoreceptor tyrosine-based 
activation motifs (ITAMs)49. There are also several cell extrinsic regulatory pathways that are 
at work, such as the regulatory T cells (Tregs) that negatively control T cell activation50,51,52. 
More ambitious developments of the theory such as considering more refined modes of 
discontinuity detection mechanisms or feedback/forward could be explored, but each of these 
refinements will also need efforts on the experimental side to generate suitable (dynamical) 
results, identify crucial questions and refine progressively our knowledge. In particular, 
whether the extrinsic control exerted by Tregs on effector cells is also governed by 
mechanisms that are described by the discontinuity theory has to be addressed experimentally 
to offer an adequate picture of this issue. However, this illustrates what is perhaps the most 
valuable benefit in having a theory: focusing investigations on most pertinent and informative 
hypotheses. 
The main claims made by the discontinuity theory can be summarized as follows. The 
sudden appearance of a structurally different motif triggers a strong effector immune 
response; it ends when the antigen is eliminated, and may lead to the generation of memory 
cells (FIG. 2A). An initially unusual but persistent motif will first trigger an effector immune 
response, but then the chronic presence of the motif will lead to the extinction of the response 
(FIG. 2B). The slow appearance of a structurally different motif leads to a very limited 
reaction, and eventually to the tolerance of this motif (FIG. 2C).  
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Why is the discontinuity theory useful? 
A unifying framework 
A new theoretical framework is accepted only if it offers both a new way of seeing things, and 
original experimental predictions (BOX 1). A major driving force in the dynamics of 
scientific theories is their growing unifying power: scientists often seek frameworks that are 
more comprehensive than their predecessors53. It is therefore important to emphasize that the 
discontinuity theory gathers under a simple explanation a range of phenomena that have 
traditionally received distinct and heterogeneous explanations. For example, effector immune 
responses to tumour cells find ad hoc explanations within the self–nonself theory, through the 
idea of the ‘altered self’39, and the ‘danger theory’54, whereas the discontinuity theory states 
that tumours trigger effector immune responses because they bear unusual motifs. When 
discontinuities in self components arise within host tissues (for example, during tumour 
development or cellular stress), an effector immune response does occur, and when non-self 
components are presented to the immune system in a progressive, continuous way (for 
example, commensal bacteria55,56), it often induces regulatory mechanisms57, and it is not 
destroyed by the immune system. Overall, the discontinuity framework should not be 
perceived as opposing previous theories (in particular the ‘self versus non-self’ and ‘danger’ 
theories) but rather as complementing and unifying them. 
 
Predictions and challenges 
The most important challenge is to determine how the discontinuity theory could help in the 
current field of immunology from a practical point of view. A key prediction made by the 
discontinuity theory is that chronicity diminishes the intensity of the immune response. 
Indeed, according to the above analysis of the dynamics of the immune response, components 
that persist for a significant period of time in the organism will tend to become increasingly 
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tolerated by the immune system. It is however important to mention that there are other 
mechanisms at work in tolerance, and that acute antigenic challenges might also be 
tolerogenic58. Nevertheless, this principle leads to several original and testable predictions.  
 First, autoimmunity, which is a chronic disorder resulting from the long-lasting 
activation of the immune system, could appear as a major counterexample. Yet our 
framework predicts two possibilities for the maintenance of chronic autoimmune disorders: 
autoantigens are changing over the course of the illness, resembling the antigenic drift 
observed in influenza virus infection59, and/or the presentation of autoantigens (i.e., their 
contextual interaction with immune effectors) is not in fact continuous, but rather oscillating 
(FIG. 2D). Obviously, this hypothesis remains to be experimentally tested. 
 Second, some massive modifications in the host, for example, such as what occurs 
during gestation or puberty in mammals, or during metamorphosis in insects or amphibians, 
do not appear to be immunogenic, in apparent conflict with the discontinuity theory. Our 
prediction is that the absence of a destructive immune response in these circumstances can be 
explained by the fact that the immune system interacts with only small quantities of these 
modified antigens, and in a progressive manner60, involving regulatory rather than activating 
processes, as documented in the case of metamorphosis61.  
 Finally, a recent study challenges the rational for the use of incomplete Freund’s 
adjuvant (IFA) emulsions for cancer vaccination. The study found that IFA emulsions 
promote antigen persistence at the vaccination site, thereby inducing T cells with an 
‘exhausted’ phenotype that eventually die62 at these sites rather than promoting their 
mobilization to the tumor sites where they are needed. In addition, repeated oral 
administration of antigen can induce tolerance and hence desensitize children with egg 
allergy63. These studies are in remarkable agreement with the discontinuity theory.  
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Conclusions and perspective 
In an attempt to assess the discontinuity theory, we sought to develop a model that translates 
the main concept of this theoretical framework into a mathematical formalism. As described 
above, the fundamental idea here is that an effector immune response is triggered by a 
discontinuity in a steady state considered as the self-referential environment. We therefore 
generated a dynamic model with an input variable E(t) encompassing all external signals 
sensed by an immune cell and an output variable R(t) quantifying the immune response 
intensity triggered by the cell (BOX 2). Despite its simplicity, this model perfectly fits the 
principles of the discontinuity theory, while presenting them in a more formal, and therefore 
testable, way. In the current model, multiple signals are modeled by a single input variable; 
while we have also developed a more complex version with a multidimensional variable 
describing different stimuli, we cannot at present assess its accuracy due to a lack of data and 
will therefore not discuss it here. 
We have thus tried here to lay the foundations for a new theory to explain how the 
immune system integrates spatial, qualitative, quantitative and temporal signals to generate an 
appropriate immune response. We suggest that the immune system has been shaped by natural 
selection for its capacity to perceive sudden antigenic modifications. This entails that the 
immune system usually deals efficiently with acute, but not with long lasting disruptions such 
as chronic infections and cancers. This view of the immune system gives rise to several 
predictions, as illustrated above through a few examples. As it stands, the discontinuity theory 
can apply to several biological scales, the cell and the populations of cells as well as the entire 
organism. Obviously, experimental testing will infirm or confirm the extent of its perimeter. 
More generally, there is little doubt that this theoretical framework will need to be amended 
and improved; the best contribution we can make along this line is to invite others to use the 
formal and empirical tools proposed here to challenge it. 
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Figures: 
Figure 1: 
Fig.1A  
 Fig.1B 
  Fig.1C 
  14 
 
 
Figure legends: 
Figure 1. NK cell tuning  
Fig. 1A: NK cells can distinguish their targets from healthy cells through the engagement of 
activating receptors and the lack of engagement of inhibitory receptors. In this example, the 
recognition of MHC-I molecules on healthy cells by the inhibitory KIR expressed on human 
NK cells induces a dominant inhibitory signal in NK cells. In contrast, cells can be modified 
as the result of various assaults such as tumor transformation or microbial infection. In these 
circumstances, molecules induced or up-regulated at the surface of the target cell, engage 
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activating receptors (such as NKG2D) leading to NK cell activation and eventually to the 
elimination of the target cells. 
 
Fig. 1B: Whereas NK cells are activated by modified cells expressing ligands for activating 
receptors, the chronic presence of activating ligands re-program NK cells that become hypo-
responsive. 
Fig. 1C: Although the absence of MHC-I expression on target cells unleashes NK cells from 
the inhibition induced by receptors such as KIR, NK cells adapt to the long lasting absence of 
MHC-I recognition. When MCH-I or KIR are not present, or when MHC-I and KIR do not 
interact, NK cells adapt to this environment by increasing their threshold of reactivity, leading 
to NK cell hypo-responsiveness. 
 
Figure 2. The triggering of an immune response according to the discontinuity theory 
The discontinuity theory states that the key to the triggering of an immune response is 
antigenic difference in a time-dependent context. If structurally different motifs appear 
suddenly (i.e., a strong quantitative difference with regard to time), then a vigorous immune 
response occurs (A), possibly followed by the generation of memory cells. In the case of a 
motif that is initially unusual but persists through time, the effector immune response is 
rapidly extinguished (B). If immune receptors interact with motifs that change very 
progressively (i.e., weak quantitative variation with regard to time), then the immune response 
is weak, and the motifs become tolerated (C). Finally, if a structurally different motif appears 
in an oscillating way, then a very strong and long-lasting immune response occurs (D). 
 
Boxes: 
Box 1: The importance of theories in biology 
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Today, theoretical thinking is often criticized for its excessive abstraction and its lack of 
utility in the everyday life of scientists. Yet, it has long been established that having a 
theoretical framework is indispensable to conduct fruitful research, and that even scientific 
observations and experiments that seem the most ‘objective’ are always, at least to some 
extent, influenced by theoretical views53,64,65. A theory can be defined as an organized set of 
testable explanatory and predictive statements. Some biological theories take the form of 
hierarchical mechanisms1, but even then they make possible the formulation of explanations 
and predictions. A purely descriptive biology (for instance, at the molecular level) would not 
give rise to true explanations and predictions, and as such it would not contribute significantly 
to the advancement of science. The formulation of theories helps scientists to determine 
where to look at, to interpret what they observe, and to develop a specific worldview. It also 
makes possible fruitful comparisons between different scientific fields66. Finally, it confronts 
scientists with the necessity to make bold predictions, with the risk of being proven wrong, 
but also with the conviction that the refutation of wrong theories is useful. Therefore, because 
theories are crucial in the formulation of explanations and in the construction of new 
experiments, it seems highly desirable that all fields of biology, including molecular ones 
such as immunology, aim at constructing new and testable theories. 
 
Box 2: A mathematical model of the discontinuity theory 
As can be seen in the following figures, our model accurately reproduces the behavior 
qualitatively illustrated in Figure 2.  
(A). Discontinuity refers to a perturbation of any environmental signal detected by the system 
in time space. Since we are interested in the variations of the inputs rather than in their values, 
R(t) will essentially be a function of the derivatives of E(t) rather than E(t) itself. Thus, 
𝑅𝑡=𝑓𝑑𝐸𝑡𝑑𝑡 
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We considered variables’ values at discrete time steps rather than a continuum in time and we 
suggested manipulating the discrete equivalent of a derivative quantity, the finite differences 
defined by: 
∆𝐸𝑡=𝐸𝑡−𝐸(𝑡−ℎ)ℎ 
where h denotes the time step. As a convention, we will take a time step equal to 1, thus in 
our case:  
∆𝐸𝑡=𝐸𝑡−𝐸(𝑡−1) 
In addition, since a central point of the discontinuity theory is the notion of adaptation, we 
took into account memory effects, so that R(t) is not only a function of 𝛥𝐸(𝑡) at the current 
time step t, but also depends on 𝛥𝐸 values at previous time steps : 
𝑅𝑡=𝑓𝛥𝐸𝑡,𝛥𝐸𝑡−1, 𝛥𝐸𝑡−2,…,𝛥𝐸𝑡−𝛿 
where 𝛿 denotes the memory parameter. 
In this first version, we thus propose the following function for R(t):  
𝑅𝑡=𝑇1𝛿𝑖=0𝑖=𝛿|𝛥𝐸(𝑡−𝑖)| 
where T(x) is a transfer function modeling the response capacity of the cell. Indeed, most if 
not all experimental data on immune responses triggered by increasing activation intensities 
indicate a threshold at lower intensities and a saturation phenomenon at higher intensities.  
We thus suggest using a sigmoidal transfer function given by: 
𝑇𝑥=𝛼1+𝑒−𝜇(𝑥−𝜏) 
where the coefficient 𝛼 will set the amplitude order of the response R(t) while 𝜇 and 𝜏 will 
determine the saturation range and the threshold at lower values of E(t). They will eventually 
have to be set using experimental data and will depend on the cell type considered, but it is 
not of great importance at this qualitative level. R(t) presents all properties that we wanted to 
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model. Indeed, R(t) will depend only on E(t) variations, will be high when these variations are 
sharp, and will return to zero as soon as E(t) is stable on the 𝛿 previous time steps which will 
correspond to the adaptation phenomenon.  
The transfer function T(x) will model both activation threshold and saturation effects of the 
cell reactivity, and will set the amplitude of the response through the parameter α. In this 
example, α=100, µ=1 and τ=5. 
(B). Comparison of the model with experimental data. Upper panel: Ca2+ flux changes in 
freshly isolated mouse splenic NK cells measured by flow  cytometry as previously described 
(S. Guia et al. 2011). Briefly, biotinylated NKG2D mAb (CX5)  was added to the cells 
followed by streptavidin  to induce NKG2D cross-linking. The stimulation is presented as the 
ratio of Indo-1 (violet) to Indo-1 (blue). Lower panel: immune cell response profile R(t) 
predicted (on 3000 time steps) by the model for an entry function , which fits with the 
experimental data presented in the upper panel. This response profile was obtained with 
parameter values:  and . In the lower panel and in panels C through E, the numbers on the y 
axis are the values of R(t) (red line) and E(t) (grey line). 
(C). Immune cell responses R(t), as a function of a Poissonian input profile [Et=βλte−λt] that 
could be associated with typical dynamics of external perturbations like infections and any 
type of injection. 
(D). Immune cell responses R(t), as a function of a sigmoid input profile [E(t)=β/(1+𝑒−λt)] 
that could be associated with typical dynamics of endogenous perturbations (interleukin 
production for instance).  
(E). Immune cell responses R(t), as a function of an oscillating input profile [𝐸𝑡=𝛽(1+cos𝜔𝑡)] 
modelling an intermittent antigen exposure. 
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